Table 2 Efficacy Outcomes.
Outcome | Total (N = 44) |
|---|---|
Best response to preoperative mFOLFIRINOX | |
Partial response | 15 (34.1%) |
Stable disease | 28 (63.6%) |
Progressive disease | 1 (2.3%) |
1-year PFS rate (95% CI) | 52.3% (37.6–67.0) |
2-year OS rate (95% CI) | 50.8% (34.5–67.1) |
Median PFS, months (95% CI) | 12.2 (8.9–15.5) |
Median OS, months (95% CI) | 24.7 (12.6–36.9) |
Surgery | 27 (61.4%) |
Median DFS from surgery, months (95% CI) (n = 27) | 10.4 (9.2–11.6) |
